Caidya logo

dMedClinical Co. Ltd.

Healthcare

Caidya Stock

Caidya is a global, full-service Contract Research Organization (CRO) offering comprehensive clinical development services. With a focus on personalized partnerships and expert knowledge, Caidya supports clients through every stage of the clinical trial process, from early-phase development to post-marketing surveillance. The company leverages cutting-edge technology and therapeutic expertise across various fields, including oncology, neurology, and rare diseases, to enhance trial efficiency and healthcare outcomes.

Founded: 2003

Caidya Website

For more Caidya stock information, or to buy or sell private shares, sign up for a MicroVentures account.

Caidya Company Overview

Founded as a result of strategic mergers, Caidya has emerged as a leading global Contract Research Organization (CRO) dedicated to supporting biopharmaceutical companies in navigating the complexities of clinical research. The company's service offerings span the entire clinical trial lifecycle, including early-phase development, regulatory services, patient recruitment, data management, and post-marketing surveillance. Caidya's approach is characterized by its commitment to personalized partnerships, tailoring solutions to meet the specific needs of each client. Caidya operates across multiple therapeutic areas, such as oncology, neurology, and infectious diseases, providing specialized knowledge that enhances the design and execution of clinical studies. The company’s global presence ensures that clients can access local expertise and resources while benefiting from harmonized technologies that streamline clinical operations. At the core of Caidya’s value proposition is its investment in cutting-edge clinical technologies. These technologies integrate various data sources to offer real-time insights, improving decision-making and trial transparency. Additionally, Caidya emphasizes collaboration and knowledge sharing, ensuring that clients are supported by experienced professionals at every stage of their clinical development journey. Led by a seasoned leadership team, Caidya is poised to drive innovation in clinical research, helping to bring new therapies to market efficiently and effectively, ultimately improving patient outcomes worldwide.

Management Team

Lingshi Tan, PhD Chairman and CEO
Simon Britton COO
Andrew Copestake PhD CCO
Sharon Moore MD Chief Medical Officer
Gaurav Sharma Chief Development Officer
John Scott MBA Chief Information Officer
David Rifkind, JD Chief Legal Officer

Funding Information